Image

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

Hypofractionated Radiotherapy and Camrelizumab for Pancreatic Cancer

Recruiting
18-75 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates hypofractionated radiotherapy combined with chemotherapy and camrelizumab as a treatment for pancreatic cancer. The purpose is to assess the surgical conversion rate and outcomes for patients with borderline resectable or locally advanced pancreatic cancer.

The study evaluates the safety and effectiveness of combining hypofractionated radiotherapy, chemotherapy, and camrelizumab. It focuses on understanding how these treatments work together to improve patient outcomes.

  • Who can participate: Adults aged 18 to 75 years with pancreatic ductal adenocarcinoma or acinar cell carcinoma may participate. Participants must have no distant metastasis and meet specific criteria regarding tumor location and resectability.
  • Study details: Participants will receive hypofractionated radiotherapy, chemotherapy, and camrelizumab. The study involves evaluating the treatment's effects on pancreatic cancer. A placebo is not used in this study.
Print
Study details
    Pancreatic Cancer

NCT06435260

Hebei Medical University Fourth Hospital

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.